Latest KFF Health News Stories
FDA Chief Calls For Stricter Scrutiny Of Electronic Health Records
In an interview, FDA Commissioner Scott Gottlieb reacts to a KHN/Fortune investigation of the drawbacks and risks of electronic health records.
Podcast: KHN’s ‘What The Health?’ Surprise! Fixing Surprise Medical Bills Is Harder Than it Looks
Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the efforts to curb “surprise” medical bills to patients who inadvertently get out-of-network care; a look at where the 2020 presidential candidates stand on health; and the Trump administration’s efforts to end HIV in the U.S. Also, Rovner interviews Food and Drug Administration Commissioner Scott Gottlieb, who is leaving his job in early April.
Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
Some plans are experimenting with the idea of closely tying hospital reimbursement rates to what Medicare pays. The approach could be a game changer in their effort to control health costs.
Did Your Doctor ‘Ghost’ You? An Employment Contract May Be To Blame
How “noncompete” clauses in contracts between doctors and hospitals or clinics prevent patients from seeing their longtime doctors.
Listen: Reporter Describes Breakdowns In Electronic Medical Records
KHN senior correspondent Fred Schulte describes a KHN-Fortune investigation into the massive push to track and share patient health care records.
Five Things To Know About The Electronic Health Records Mess
The U.S. government claimed that ditching paper medical charts for electronic records would make health care better, safer and cheaper. Ten years and $36 billion later, the digital revolution has gone awry.
Death By 1,000 Clicks: Where Electronic Health Records Went Wrong
The U.S. government claimed that turning American medical charts into electronic records would make health care better, safer and cheaper. Ten years and $36 billion later, the system is an unholy mess. Inside a digital revolution that took a bad turn.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
How Much Difference Will Eli Lilly’s Half-Price Insulin Make?
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
Military Doctors In Crosshairs Of A Budget Battle
Details of the reductions have not yet been announced, but in 2017 Congress ordered mandated changes to make the military health system more efficient.
FDA Announces Sweeping Plan To Review Safety Of Surgical Staplers
The FDA said it might reclassify the widely used devices featured in a recent Kaiser Health News investigation.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
As Hospitals Post Price Lists, Consumers Are Asked To Check Up On Them
Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.
Lawmakers United Against High Drug Prices Bare Partisan Teeth
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Podcast: KHN’s ‘What The Health?’ What’s Next For The FDA?
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
Hidden FDA Reports Detail Harm Caused By Scores Of Medical Devices
The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.
Ciudades y condados seguirán importando medicamentos, a pesar de alertas de la FDA
Varios estados, entre ellos Florida y Nueva York, dijeron que continuarán usando una compañía canadiense para ofrecer a sus empleados medicamentos recetados a bajo precio.
Cities And Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
Texas Lawmakers Take Aim At Surprise Medical Bills
A proposed state law with bipartisan, bicameral support is on the move in Texas. It would force hospitals and insurers to settle surprise bills — instead of relying on patients to start the mediation process. The KHN/NPR “Bill of the Month” series is a catalyst for the effort.
